Agilent Technologies A FX & Other Adjustments

FX & Other Adjustments at other companies

RevvityRVTY

——

Bio-Rad LaboratoriesBIO

——

Agilent Cross Lab$0-100%

Revenue$1.8B+10.0%

Gross profit$990.0M+14.3%

Operating income$399.0M+33.0%

Net income$339.0M+57.7%

EPS (diluted)$1.20+60.0%

Cash & equivalents$1.8B+21.5%

Total debt$3.5B-3.9%

Total equity$7.1B+16.1%

Total assets$13.1B+7.5%

Operating cash flow$277.0M+25.3%

CapEx$76.0M-33.3%

Free cash flow$201.0M+87.9%

Market cap$38.41B+15.0%

Enterprise value$40.15B+12.7%

P/E27.2×-1.5×

P/S5.3×+0.3×

Gross margin52.7%-0.6pp

Operating margin21.5%+0.1pp

Net margin19.6%+2.0pp

FCF margin15%-2.9pp

Return on equity21.3%+2.4pp

Debt / equity0.5×-0.1×

Current ratio2.1×0.0×